Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2016-3051
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM Security Access Manager for Web 9.0.0 could allow an authenticated user to access some privileged functionality of the server. IBM X-Force ID: 114714.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM Security Access Manager for Web 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM Security Access Manager（ISAM）for Web（前称IBM Tivoli Access Manager for e-business）是美国IBM公司的一套用于用户认证、授权和Web单点登录解决方案中的产品，它提供用户访问管理和Web应用保护功能。 ISAM for Web中存在安全漏洞。攻击者可利用该漏洞获取服务器访问权限。以下版本受到影响：IBM Security Access Manager 9.0版本至9.0.2.0版本。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMSecurity Access Manager 9.0.0.1 -
II. Public POCs for CVE-2016-3051
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2016-3051
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: Security Access Manager
Same vendor: IBM
V. Comments for CVE-2016-3051

No comments yet

Leave a comment